Dell Children's Blood and Cancer Center

Austin, Texas 78723

5 studies enrolling now · 10 studies all time

What they study most

Brain Tumors, Choroid Plexus Neoplasms, Clear Cell Sarcoma, Craniopharyngioma, Dysembryoplastic Neuroepithelial Tumor, Ependymoma, Ewings Sarcoma, Germ Cell Tumors, Glioma, Liver Tumors, Malignant Rhabdoid Tumor, Medulloblastoma

Studies at this site

• Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma — Recruiting now
• DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma — Recruiting now
• Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma — Recruiting now
• Pediatric Precision Laboratory Advanced Neuroblastoma Therapy — Recruiting now
• Beat Childhood Cancer Specimen Banking and Data Registry — Recruiting now
• Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma — Running, not enrolling
• Neuroblastoma Maintenance Therapy Trial — Running, not enrolling
• Molecular-Guided Therapy for Childhood Cancer — Completed
• Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer — Completed
• Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission — Completed